Evidence map›Paper›PMID 26240704›Full record

ReviewWorld journal of diabetes2015

Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review.

Héctor Eloy Tamez-Pérez, Dania Lizet Quintanilla-Flores, René Rodríguez-Gutiérrez, José Gerardo González-González, Alejandra Lorena Tamez-Peña

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in World journal of diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06478186 (RCT to Evaluate the Effects of Zilretta), which is not on this map. Cited by 183 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
183citing papers in PubMed, 7 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06478186 phase4recruitingnot on this mapstarted 2024, after this paper: background citation

RCT to Evaluate the Effects of Zilretta (Triamcinolone Acetonide- Extended Release) and Kenalog (Triamcinolone Acetonide- Immediate Release) on Blood Glucose in Subjects With Osteoarthritis of the Knee and Type 2 Diabetes Mellitus

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2024 to 2027Enrolled120ConditionsOsteoarthritis, Knee, Diabetes Mellitus, Type 2Armstriamcinolone acetonide extended-release injectable suspension, TCA-ER, Triamcinolone Acetonide- Immediate Release, TCA-IR
3 · Its place in the literature

Who cites it

183 citing papers in PubMed, 7 syntheses or guidelines pooled it, 377 citations in OpenAlex.

  1. [Hospital diabetes management (Update 2026)].Wiener klinische Wochenschrift · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Article
  11. Isolated oculomotor nerve palsy as the sole presenting feature of neurobrucellosis: a case report.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

123 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Héctor Eloy Tamez-PérezHéctor Eloy Tamez-Pérez, Dania Lizet Quintanilla-Flores, Alejandra Lorena Tamez-Peña, Internal Medicine Service, "Dr. José Eleuterio González" University Hospital and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
Dania Lizet Quintanilla-FloresHéctor Eloy Tamez-Pérez, Dania Lizet Quintanilla-Flores, Alejandra Lorena Tamez-Peña, Internal Medicine Service, "Dr. José Eleuterio González" University Hospital and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
René Rodríguez-GutiérrezHéctor Eloy Tamez-Pérez, Dania Lizet Quintanilla-Flores, Alejandra Lorena Tamez-Peña, Internal Medicine Service, "Dr. José Eleuterio González" University Hospital and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
José Gerardo González-GonzálezHéctor Eloy Tamez-Pérez, Dania Lizet Quintanilla-Flores, Alejandra Lorena Tamez-Peña, Internal Medicine Service, "Dr. José Eleuterio González" University Hospital and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
Alejandra Lorena Tamez-PeñaHéctor Eloy Tamez-Pérez, Dania Lizet Quintanilla-Flores, Alejandra Lorena Tamez-Peña, Internal Medicine Service, "Dr. José Eleuterio González" University Hospital and School of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León 64460, México.
Universidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steroids are drugs that have been used extensively in a variety of conditions. Although widely prescribed for their anti-inflammatory and immunosuppressive properties, glucocorticoids have several side effects, being hyperglycemia one of the most common and representative. In the present review, we discuss the main epidemiologic characteristics associated with steroid use, with emphasis on the identification of high risk populations. Additionally we present the pathophysiology of corticosteroid induced hyperglycemia as well as the pharmacokinetics and pharmacodynamics associated with steroid use. We propose a treatment strategy based on previous reports and the understanding of the mechanism of action of both, the different types of glucocorticoids and the treatment options, in both the ambulatory and the hospital setting. Finally, we present some of the recent scientific advances as well as some options for future use of glucocorticoids.

Indexed as

Diabetes mellitusHyperglycemiaInsulinSteroidTreatment

Identifiers

PMID26240704
PMCPMC4515447
OpenAlexW2411105639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.